Evidence-Based Medicine Guidelines
Foetal fibronectin testing for reducing the risk of preterm birth
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Foetal Fibronectin Testing for Reducing the Risk of Preterm Birth." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth.
Foetal fibronectin testing for reducing the risk of preterm birth. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth. Accessed April 28, 2025.
Foetal fibronectin testing for reducing the risk of preterm birth. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth
Foetal Fibronectin Testing for Reducing the Risk of Preterm Birth [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Foetal fibronectin testing for reducing the risk of preterm birth
ID - 450322
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
